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A new method for isolation ofeukaryotic topoisomcrase 1 from calf thymusand from Jurkat-l cells using HPLC has been developed. The method 
allows quantitative purificntion of high molLvular weight topo I and of two low molecular weight fractions differing by their isoelectric points. It 
has been suggested that these fractions bc characterized as two subforms of the enzyme possessing structural and functional diffcrcnccs. The 
differences in their specific activities, sensitivity to camptothccin and in their protcolytic digestion maps have been demonstrated for the two 
cnzymcs. 
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1. lNTRODUCTlON 
The type I topoisomerases (topo I) are key er~qmcs 
in the control of DNA topological state changes neccs- 
sary for many genetic processes [l]. 
The procedure for isolation of topo I from calf thy- 
mus [2] and some other tissues [3] yields several pol- 
ypeptides of different molecular weight. The same phe- 
nomenon was found in prokaryotic cells [4]. This might 
be due to partial proteolysis of the native topo I of high 
molecular weight. Here we suggest hat this phenome- 
non can be caused also by another reason. 
2. EXPERIMENTAL 
2.1. PtwiJiccttion of type I ropoisottwosc 
Topo 1 was initially purified from calf thymus and Jurkat-I cells as 
described [3]. Then we developed our original HPLC protocol. The 
Altex (Beckman, Model 332) HPLC system WBS used. All steps were 
carried out at 4OC with buffers containing 1.4 mM 2-mercaptorthanol 
(M)3) and I mM PMSF; the flow rate was 0.5 ml/min. 
The active fraction cluting from a heparin-Scpharose column was 
dilutLti to a concentration of 5% glycerol. Solid ammonium sulfate 
(AS) was slowly added to 33% saturation, and after stirring for GO min 
the precipitate was removed by ccnlrifugation (I 3,000 x 6, I5 min). 
The supernatnnt was applied to Phenyl SPW (TSK column), cquili- 
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bratcd with buffer A, containing 50 mM potassium phosphate buffer 
(KPB), pH 7.3. and 33% saturation with AS. Elution was performed 
with an increasing linear gradient of buffer B, containing 50 mM KPB, 
pH 7.2. and 30% cthylcnc glycol. After dialysis against 50 mM KPB, 
pH 7.2, and 20% glycerol (buffer C), specific topo I activity was found 
in the bound and unbound fractions. The last was loaded onto a Mono 
Q column, and the unbound fraction from the Mono Q coiumn was 
then loaded directly onto a Mono S column: at this point all the 
activity was bound to the column. Both columns were ctquilibratcd 
with buffer C and in both cases the elution was performed with aa 
increasing linear gradient of 50 mM KPB, pH 7.2, 20% glycerol and 
1 M N&l (buffer D). 
2.2. Other procedures 
Topo I activity was measured by the relaxation ofsuperwiled pIas_ 
mid DNA (pUCl9) [5]. One unit was defined as the amount of cnzymc 
that relaxes half of the added plasmid DNA (1 pg) in IO min at 25%. 
The assay was also carried out with eamptothccin (CPT) at different 
concentrations. Isoelectric focusinfi with subseauent immunodctcc- 
lion w3s done as in [6]. Partial digkion of subfkrms of topo I with 
protease from the VS strain of Sfophytococctu cmrcus (Bochringer- 
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Scheme I. Schcmc of purification of lopoisomcrase 1. 
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Mannheim) was carried out in IOrnM Tris-HCI, pH 7.5, I mM EDTA, 
10% glycerol and 150 mM NaCI. A proteasc to topo 1 ratio f I:50 
was used in all cases. SDS-PAGE was done as described [7]. 
3. RESULTS AND DISCUSSION 
The proposed purification procedure is displayed in 
Scheme 1. The introduction of the hydrophobic interac- 
tion HPLC step allowed us to separate low and high 
molecular weight topo I and gave a quantitative yield 
of topo I/130-145 (Fig. 1A). Mono Q HPLC was the 
20 40 60 
‘Piane ( min > 
Fig. I. HPLC of topo I on Phenyl 5PW (A), Mono Q (l3) and Mono 




Fig. 2. SDS-PAGE (7.5% gel) of the purified subformsof topo I. Lane 
1, the Mono Q fraction. The two sepnratd fractions of topo I were 
purified on a Mono S column: lane 2, the last 113 01’ the protein peak 
(top0 I/72); lane 3, its Rrst 33 (topo I/70-75); lane 4, topo I cluted from 
Phenyl 5PW. Immunoblotting (data not shown) indicated that all 
these proteins were topo I. 
268 
Volume 314, number 3 FEBS LETTERS lkcemlxr 1992 
Table I 
PurificaGon of ~opo I subforms from calf thymus (500 g tissue) 








I. PEG supcrnatant 
II. 1st hydroxylapatitc 
III. 2nd hydroxylapatilc 
IV. Hcparin-Scpharosc 
V. HPLC on Phcnyl SPW 
VI. HPLC on Mono Q 
VII. HPLC on Mono S 
I .ooo 2.000 175 IO0 
300 I50 2.0 x 10’ BB 
50 IO 2.G x lo’ 74 
7 4.1 6.2 x loa 72 
2.5 2.5 5.0 x IO3 36 
I.5 0.4 1.5 x 10’ I7 
I.5 0.75 7.0 x IO’ I5 
The total yield or all topo I fractions (steps V-VII) was 68%. The concentration oT proteins was cytimated 
ils in [8]. 
second step in our protocol (Fig. 16). Activity bound 
to the column proved to be homogeneous topo I/66. A 
pl = 6.0 was determined for this topo I Fraction, whereas 
the usual pl of topo I is in a narrow range between 8.1 
and 8.3. The large loss of specific activity observed by 
Schmitt et al. at the last step of purification of topo I 
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Fig. 3. SDS-PAGE (12.5% gel) of the products of’ partial digestion oT 
the subforms of topo I with prolease from the V8 strain of Srupltylo- 
COCC((S UUI-~IIS. Lnncs I and 2, digestion 61‘ topo l/&i with the protcasc 
lbr 16 h at 25°C and for 3 h at 37°C. rrsptilivtiiy. ianas 3 aiid 4, 
digestion of topo I/72 with the proteasc for IC h at 25°C and for 3 h 
at 37OC, respruldvrly. Lane 5, V8 protease; lane M. mol. wt. markers 
in kDa. 
on Bio-Rex 70 [2] could account for failure to identify 
this fraction. The unbound fraction from the Mono Q 
MPLC step was purified on a Mono S column (Fig. 1C) 
and gave topo 1 similar to those from Bio-Rex 70 elu- 
tion (specifically topo l/72 with p1 = 8.1). Each step of 
the purification procedure is charactcrizi::d in Table 1. 
SDS-PAGE of all obtained topo 1 fractions is presented 
in Fig. 2. 
The dramatically different behaviour of these pro- 
teins of close molecular weights when using different 
ion-exchange supports allowed us to suppose that this 
could be due to structural differences of the topo I 
fractions. This assumption needed strong functional 
and structural support. 
We showed that the isolated subforms had different 
proteolytic digestion patterns (Fig. 3), specific activities 
(2 x lo5 and 1 x lo5 U for topo I/66 and topo I/72, 
respectively) and differed greatly in their sensitivity to 
CPT (Fig. 4). Topo I/72 was inhibited by CPT at 5 PM, 
whilst topo l/G6 appeared to be CPT resistant, even at 
625 ,uM. 
The differences in properties of the subforms may be 
caused by post-translational modification of topo I/66. 
The observed correlation of the specific activity of topo 
1 with its modification [9] supports this idea, although 
more probably it can be explained by the structural 
difKerences of this subform of topo I. The different sen- 
Fig, 4. Effcc~ of CPT on top0 l/G6 and topo Y72. Lane I. plasmid 
DNA pLJCI9; OC, open circular DNA; CC, closed circular plasmid 
f3XA. The cilzjmn..~ -..I l :- *I-*‘a&y !sas assayed in the absence (lanes 2.9) 
and presence of CPT at 0.2 (lanes 3,10), 1.0 (lanes 4,l I), 5.0 (lanes 
5,12), 25 (lanes G.l3), I25 (lanes 7.14)and 625yM (lanes 8,15), rcspcc- 
lively. 
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sitivity to CFT may confirm this proposal as it has been 
demonstrated that mutations could affect this property 
of the enzyme [lo], although the CPT-resistmt topo I 
described here had no delectable differences in its pep- 
tide map in comparison lyith wild-type topo I. In our 
investigation two forms ol’eukaryotic topo I of different 
sensitivity to CRT had dramatic differences in prote- 
olytic patterns, allowing us to suggest differences of 
these enzymes in their primary structures. 
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